Page 22 - GALENIKA MEDICAL JOURNAL

Literatura 20. Wang TKM, Abou Hassan OK, Jaber W, Xu B. Multi-modality imaging of
cardiac amyloidosis: Contemporary update. World J Radiol. 2020 Jun
28;12(6):87-100.
1. Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der Bruggen 21. Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS.
W, Mohan HK, et al; EANM Bone & Joint Committee and the Oncology 99m Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac
Committee. The EANM practice guidelines for bone scintigraphy. Eur J amyloidosis from the transthyretin-related familial and senile cardiac
Nucl Med Mol Imaging. 2016 Aug; 43(9):1723-38. amyloidoses. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201.
2. Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, 22. Narotsky DL, Castano A, Weinsaft JW, Bokhari S, Maurer MS. Wild-Type
Sekijima Y, et al. Amyloid nomenclature 2018: recommendations by the Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced
International Society of Amyloidosis (ISA) nomenclature committee. Imaging. Can J Cardiol. 2016 Sep;32(9):1166.e1-1166.e10.
Amyloid. 2018 Dec; 25(4):215-9.
23. Jansen DE, Corbett JR, Buja LM, Hansen C, Ugolini V, Parkey RW, et al.
3. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Quantification of myocardial injury produced by temporary coronary
Diagnosis and treatment of cardiac amyloidosis: a position statement artery occlusion and reflow with technetium-99m-pyrophosphate.
of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Circulation. 1987 Mar;75(3):611-7.
Heart J. 2021 Apr 21; 42(16):1554-68.
4. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin 24. Roteta Unceta Barrenechea A, Aibar Arregui MA, Nogueira Souto
D, Melero Polo J, Moreno Gázquez I, Tardin Cardoso L, et al. Cardiac
Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Transthyretin Amyloidosis: A Nuclear Medicine Leading Role. Situation
Cardiol. 2019 Jun 11;73(22):2872-91. in a Spanish Center and "State of the Art" in Nuclear Medicine. Clin Nucl
5. Bloom MW, Gorevic PD. Cardiac Amyloidosis. Ann Intern Med. 2023 Med. 2021 Jun 1;46(6):456-64.
Mar;176(3):ITC33-ITC48. 25. Longhi S, Bonfiglioli R, Obici L, Gagliardi C, Milandri A, Lorenzini M, et
6. Bhogal S, Ladia V, Sitwala P, Cook E, Bajaj K, Ramu V, et al. Cardiac al. Etiology of amyloidosis determines myocardial 99m Tc-DPD uptake in
Amyloidosis: An Updated Review With Emphasis on Diagnosis and amyloidotic cardiomyopathy. Clin Nucl Med. 2015 May;40(5):446-7.
Future Directions. Curr Probl Cardiol. 2018 Jan;43(1):10-34. 26. Angelini A, Zanco F, Castellani C, Di Francesco, A, Della Barbera M,
7. Gertz MA. Cardiac Amyloidosis. Heart Fail Clin. 2022 Jul;18(3):479-88. Vescovo GM, et al. Cardiac amyloidosis: a review of the literature and a
practical approach for the clinicians. Italian Journal of Medicine. 2019;
8. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang 13(2): 73–90.
PP, Eisen HJ, et al; American Heart Association Heart Failure and
Transplantation Committee of the Council on Clinical Cardiology. 27. Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA,
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Giubbini R, et al. Diagnostic accuracy of bone scintigraphy in the
Statement From the American Heart Association. Circulation. 2020 Jul assessment of cardiac transthyretin-related amyloidosis: a bivariate
7;142(1):e7-e22. meta-analysis. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1945-55.
9. Martinez-Naharro A, Patel R, Kotecha T, Karia N, Ioannou A, Petrie A, 28. Hanna M, Ruberg FL, Maurer MS, Dispenzieri A, Dorbala S, Falk RH, et
et al. Cardiovascular magnetic resonance in light-chain amyloidosis to al. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking
guide treatment. Eur Heart J. 2022 Dec 1;43(45):4722-35. Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. J Am
Coll Cardiol. 2020 Jun 9;75(22):2851-62.
10. Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk
T, et al. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac 29. Sebastián Palacid F, Álvarez Mena N, Del Carmen Zambrano Infantino
Amyloidosis. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):69-80. R, García Aragón M, Alonso Rodríguez M, Pérez López B, et al. Absolute
quantification of myocardial uptake of 99m Tc-DPD in patients with
11. Costa J, Bichon L, Maouche A, Durdon P, Pouy R, Robbins A. (2021). cardiac amyloidosis due to transthyretin deposits (ATTR). Rev Esp Med
Evaluation of Perugini score and myocardial mass and voltage Nucl Imagen Mol (Engl Ed). 2023 Sep-Oct;42(5):302-9.
abnormalities in transthyretine cardiac amyloidosis. European Heart
Journal. 30. Pandey S, Teruya S, Rodriguez C, Deluca A, Kinkhabwala M, Johnson LL,
et al. Diagnostic performance characteristics of planar quantitative and
12. Fukuzawa S, Okino S, Ishiwaki H, Iwata Y, Uchiyama T, Kuroiwa N, et al. semi-quantitative parameters of 99m Tc pyrophosphate (PYP) imaging
Positive Myocardial Uptake of Bone Scintigraphic Agents Associated for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP
with Cardiac Amyloidosis: Frequency of Positive Uptake Data Based on study. J Nucl Cardiol. 2023 Aug;30(4):1414-9.
Daily Clinical Practice. Ann Nucl Cardiol. 2020;6(1):27-32.
31. Alexander KM, Masri A. Recipe for Success in Transthyretin
13. Lades G, Carpenet H, Benoit U, Aboyans V, Monteil J. Tc-99m HMDP Cardiomyopathy: Monoclonal Protein Rule Out, SPECT Imaging, and
bone scintigraphy for cardiac amyloidosis diagnosis: A false positive Genetic Testing. JACC Cardiovasc Imaging. 2021 Jun;14(6):1232-4.
case. J Nucl Cardiol. 2022 Aug;29(4):2051-2.
32. Briasoulis A, Bampatsias D, Papamichail A, Kuno T, Skoularigis J,
14. Mattana F, Muraglia L, Girardi F, Cerio I, Porcari A, Dore F, et al. Clinical Xanthopoulos A, et al. Invasive and Non-Invasive Diagnostic Pathways
application of cardiac scintigraphy with bone tracers: controversies and in the Diagnosis of Cardiac Amyloidosis. J Cardiovasc Dev Dis. 2023 Jun
pitfalls in cardiac amyloidosis. Vessel Plus 2022;6:13. 11;10(6):256.
15. Hutt DF, Fontana M, Burniston M, Quigley AM, Petrie A, Ross JC, et al. 33. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al.
Prognostic utility of the Perugini grading of 99m Tc-DPD scintigraphy ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus
in transthyretin (ATTR) amyloidosis and its relationship with skeletal Recommendations for Multimodality Imaging in Cardiac Amyloidosis:
muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging. 2017 Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circ
Dec 1;18(12):1344-50. Cardiovasc Imaging. 2021 Jul;14(7):e000029.
16. Miller RJH, Cadet S, Mah D, Pournazari P, Chan D, Fine NM, et al. 34. Bokhari S, Shahzad R, Castaño A, Maurer MS. Nuclear imaging
Diagnostic and prognostic value of Technetium-99m pyrophosphate modalities for cardiac amyloidosis. J Nucl Cardiol. 2014 Feb;21(1):175-
uptake quantitation for transthyretin cardiac amyloidosis. J Nucl 84.
Cardiol. 2021 Oct;28(5):1835-45.
35. Petrovic M, Lopez PD, Eng C, Rashid M. Myocardial Scintigraphy in
17. Scully PR, Morris E, Patel KP, Treibel TA, Burniston M, Klotz E, et al. DPD Diagnosing Cardiac Transthyretin Amyloidosis. Tex Heart Inst J. 2022 Jul
Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker. JACC 1;49(4):e207379.
Cardiovasc Imaging. 2020 Jun;13(6):1353-63.
18. Writing Committee; Kittleson MM, Ruberg FL, Ambardekar AV,
Brannagan TH, Cheng RK, Clarke JO, et al. 2023 ACC Expert Consensus Konflikt interesa: Nema
Decision Pathway on Comprehensive Multidisciplinary Care for the
Patient With Cardiac Amyloidosis: A Report of the American College of Primljeno: 05. 02. 2024.
Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 Prihvaćeno: 20. 02. 2024.
Mar 21;81(11):1076-126.
Onlajn: 01. 06. 2024.
19. Maurer MS. Noninvasive Identification of ATTRwt Cardiac Amyloid: The
Re-emergence of Nuclear Cardiology. Am J Med. 2015 Dec;128(12):1275-
80.

20 DOI: 10.5937/Galmed2410019C